Biopharmaceutical Contract Manufacturing Market Report by 2028

    Biopharmaceutical Contract Manufacturing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Biologics and Biosimilar); Service (Process Development, Fill and Finish Operations, Analytical and Quality Control Studies, and Packaging), and Source (Mammalian and Microbial-Based Biologics/Non-Mammalian), and Geography

    Publication Month: Feb 2022 | Report Code: TIPRE00005512 | No. of Pages: 211 | Category: Pharmaceuticals | Status: Published

    The biopharmaceutical contract manufacturing market is projected to reach US$ 27,868.50 million by 2028 from US$ 15,735.04 million in 2021; it is expected to grow at a CAGR of 8.5% from 2021 to 2028.

    The rising outsourcing by pharmaceutical companies is one of the most key factors driving the growth of the market. A few years ago, the contract manufacturing industry was a niche service market offering additional manufacturing capacity or specific services to pharmaceutical companies. The rise of CMOs was fueled by the increasing number of drug manufacturing failures. In the past, pharmaceutical companies had undertaken manufacturing facilities to develop innovative drugs. However, to reduce the risk of overcapacities, the demand for manufacturing outsourcing has continuously risen. Recently, Revolo Biotherapeutics entered into a partnership with contract development and manufacturing organization (CDMO)—Northway Biotech—to manufacture Revolo’s binding immuno-regulatory protein 1805. The partnership included services from cell line development to manufacturing protein with quality assurance and regulatory compliance support. Similarly, Gland Pharma has been manufacturing Remdesivir for four companies, including Mylan, since 2021. Also, the organization increased its manufacturing quotas due to high demand from the companies. In 2019, Samsung Biologics and GI Innovation signed a contract for immunochemotherapy. Under this agreement, Samsung Biologics was providing services ranging from f-cell lines development to production of Phase-I drug substances. The increasing number of contracts between biopharmaceutical companies and contract manufacturing companies shows an increasing market size for the biopharmaceutical contract manufacturing market.

    North America is likely to continue its dominance in the biopharmaceutical contract manufacturing market during 2021–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period. Increasing demand for clinical trials, growing pharmaceutical and medical device industries, increasing healthcare expenditure, high R&D spending, and the presence of key market players in the region that offer manufacturing, storage, logistic, and other services is likely to enhance the market growth in the country. For instance, Alderley Analytical, Almac, and among others are well-known manufacturing organizations that offer a wide range of integrated services to more than 600 pharmaceutical and biotech companies. The presence and significant impact of biopharmaceutical companies in the region in terms of revenue, technology, and employment opportunities are expected to aid the growth of the market in the region.

    Strategic Insights

    Lucrative Regions for Biopharmaceutical Contract Manufacturing Market

    Lucrative Regions for Biopharmaceutical Contract Manufacturing Market

    Get more information on this report :

    Market Insights

    Increasing Demand for Biologics Drives Market Growth

    The contract manufacturing market for biologics is growing at an unprecedented rate owing to increasing biologics pipeline, manufacturing complexity, and companies shifting their focus towards core activities. Presently, many pharmaceutical and biotechnology companies outsource varied services from early-stage drug development to commercial-scale manufacturing. Outsourcing is required to expedite research and development, speed up market entry, give access to novel technologies, regulatory expertise, and reduce risks at a competitive cost. Complexities in biologics development and production and increasingly stringent quality standards have driven drug manufacturers to prefer contract manufacturer services. Moreover, many companies are opting CMOs services to speed up the development process and lower production costs. For instance, Sanofi has outsourced manufacturing of its biologics pipeline to Boehringer Ingelheim. Moreover, TaiMed Biologics Ibalizumab (the FDA-designated orphan drug) is manufactured by CMO WuXi PharmaTech. Also, in 2021, Samsung Biologics expanded its collaboration with AstraZeneca from 2020. The contract included the production of a drug substance, AstraZeneca’s COVID-19 long-acting antibody combination, and manufacturing of a cancer immunotherapy product started from 2022.

    Product-Based Insights

    Based on product, biopharmaceuticals contract manufacturing market is segmented into biosimilar and biologics. The biologics segment held the largest share of the market in 2021 owing to increasing demand for biologics, increasing research, and development activities to develop new drugs for chronic indications in the forecast period. The segment is further segmented into monoclonal antibodies, recombinant proteins, vaccines, and others. The market for biosimilar is expected to register the highest CAGR in the market during the forecast period due to patent expiration of blockbuster drugs and increasing pipeline.

    Biopharmaceutical Contract Manufacturing Market, by Product– 2021 and 2028

    Biopharmaceutical Contract Manufacturing Market, by Product– 2021 and 2028

    Get more information on this report :

    Service Insights

    The biopharmaceuticals contract manufacturing market, by service, is segmented into process development, fill and finish operations, analytical and quality control studies, and packaging. In 2021, the process development accounted for the largest market share in the global biopharmaceuticals contract manufacturing market owing to higher focus on pilot to commercial scale-up process development, cell line development, and other processes. However, analytical and quality control studies are expected to grow at a significant CAGR in the forecast period owing to stringent regulatory regulation and complex manufacturing requirements for biologics.

    Companies operating in the biopharmaceutical contract manufacturing market adopt product innovation strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market. Also, the companies in the market create partnerships, collaborations, and contracts with biopharmaceutical companies to further drive the revenue of the market.

    Biopharmaceutical Contract Manufacturing Market – Segmentation

    Based on the product, the biopharmaceutical contract manufacturing market is segmented into biologics and biosimilar. The biologics segment is further segmented into monoclonal antibodies, recombinant proteins, vaccines, and others.

    By service, the biopharmaceutical contract manufacturing market is segmented into process development, fill and finish operations, analytical and quality control studies, and packaging.

    Based on the source, the biopharmaceutical contract manufacturing market is segmented into mammalian and microbial-based biologics/non-mammalian.

    Biopharmaceutical Contract Manufacturing Market – by Geography

    Based on geography, the biopharmaceutical contract management market is primarily segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The market in North America is further segmented into the US, Canada, and Mexico. The European biopharmaceutical contract management market is sub-segmented into Germany, France, the UK, Spain, Italy, and the Rest of Europe. The market in the Asia Pacific is sub-segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. The biopharmaceutical contract management market in the Middle East and Africa is further segmented into Saudi Arabia, the UAE, South Africa, and the Rest of the Middle East and Africa. The market in South and Central America is sub-segmented into Brazil, Argentina, and the Rest of South and Central America.

    Company Profiles

    • Lonza AG
    • Boehringer Ingelheim Biopharmaceuticals GmbH
    • Inno Bio Ventures Sdn Bhd
    • Thermo Fisher Scientific, Inc.
    • AbbVie, Inc.
    • WuXi Biologics, Inc.
    • General Electric Co.
    • Samsung Biologics Co. Ltd.
    • Merck KGaA
    • Ajinomoto Co. Inc.

    Frequently Asked Questions

    Biopharmaceuticals contract manufacturing refers to biopharmaceutical companies outsourcing the development and manufacturing of drugs substances and products to contract manufacturers with the necessary resources to manufacture their products. Biopharmaceutical contract manufacturing organizations (CMOs) have become a known name among pharmaceutical companies due to their cost effective services that require minimal capital investments by the biopharmaceutical company. The CMOs offer a wide range of services including process development, analytical and quality control studies, fill and finish operations, and packaging. Moreover, the growing biopharma industry is offering lucrative opportunities for the growth of the market.
    The factors that are driving the growth of the market are increasing demand for biologics, growing biosimilar pipelines, stringent regulatory guidelines, and increasing outsourcing by pharmaceutical companies. Moreover, emerging markets are offering lucrative opportunities owing to the increasing number of contract manufacturers in developing countries.
    The biopharmaceutical contract manufacturing market majorly consists of the players such as Lonza AG, Boehringer Ingelheim Biopharmaceuticals GmbH, Inno Bio Ventures Sdn Bhd, Thermo Fisher Scientific, Inc., AbbVie, Inc., WuXi Biologics, Inc., General Electric Co., Samsung Biologics Co. Ltd., Merck KGaA, and Ajinomoto Co. Inc., among others.

    1. Introduction

    1.1 Study Scope

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global Biopharmaceutical Contract Manufacturing Market – By Product

    1.3.2 Global Biopharmaceutical Contract Manufacturing Market – By Service

    1.3.3 Global Biopharmaceutical Contract Manufacturing Market – By Source

    1.3.4 Global Biopharmaceutical Contract Manufacturing Market – By Geography

    2. Biopharmaceutical Contract Manufacturing Market – Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Biopharmaceutical Contract Manufacturing – Market Landscape

    4.1 Overview

    4.2 PEST Analysis

    4.2.1 North America – PEST Analysis

    4.2.2 Europe – PEST Analysis

    4.2.3 Asia Pacific – PEST Analysis

    4.2.4 Middle East and Africa (MEA) – PEST Analysis

    4.2.5 South and Central America – PEST Analysis

    4.3 Expert Opinion

    5. Biopharmaceuticals Contract Manufacturing Market – Key Market Dynamics

    5.1 Market Drivers

    5.1.1 Rising Outsourcing by Pharmaceutical Companies

    5.1.2 Increasing Demand for Biologics

    5.2 Market Restraints

    5.2.1 Growing Competition in Industry

    5.3 Market Opportunities

    5.3.1 Emerging Markets

    5.4 Future Trends

    5.4.1 Consolidation in Pharmaceutical CMO Industry

    5.4.2 COVID-19 Pandemic

    5.5 Impact Analysis

    6. Biopharmaceutical Contract Manufacturing Market – Global Analysis

    6.1 Global Biopharmaceutical Contract Manufacturing Market Revenue Forecast and Analysis

    6.2 Global Biopharmaceutical Contract Manufacturing Market, By Geography - Forecast And Analysis

    6.3 Market Positioning of Key Players

    7. Biopharmaceuticals Contract Manufacturing Market Analysis – By Product

    7.1 Overview

    7.2 Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2021 and 2028)

    7.3 Biologics

    7.3.1 Overview

    7.3.2 Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.2.1 Monoclonal Antibodies

    7.3.2.1.1 Overview

    7.3.2.1.2 Monoclonal Antibodies: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.2.2 Recombinant Proteins

    7.3.2.2.1 Overview

    7.3.2.2.2 Recombinant Proteins: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.2.3 Vaccines

    7.3.2.3.1 Overview

    7.3.2.3.2 Vaccines: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    7.3.2.4 Others

    7.3.2.4.1 Overview

    7.3.2.4.2 Others: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    7.4 Biosimilar

    7.4.1 Overview

    7.4.2 Biosimilar: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    8. Biopharmaceuticals Contract Manufacturing Market – By Service

    8.1 Overview

    8.2 Biopharmaceuticals Contract Manufacturing Market, by Service, 2021 and 2028 (%)

    8.3 Process Development

    8.3.1 Overview

    8.3.2 Process Development: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    8.3.2.1 Downstream Processing

    8.3.2.1.1 Overview

    8.3.2.1.2 Downstream Processing: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    8.3.2.2 Upstream Processing

    8.3.2.2.1 Overview

    8.3.2.2.2 Upstream Processing: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    8.4 Fill and Finish Operations

    8.4.1 Overview

    8.4.2 Fill and Finish Operations: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    8.5 Analytical and Quality Control Studies

    8.5.1 Overview

    8.5.2 Analytical and Quality Control Studies: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    8.6 Packaging

    8.6.1 Overview

    8.6.2 Packaging: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    9. Biopharmaceuticals Contract Manufacturing Market – By Source

    9.1 Overview

    9.2 Biopharmaceuticals Contract Manufacturing Market, by Source, 2021 and 2028 (%)

    9.3 Mammalian-Based Biologics

    9.3.1 Overview

    9.3.2 Mammalian-Based Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    9.4 Microbial/Non-Mammalian-Based Biologics

    9.4.1 Overview

    9.4.2 Microbial/Non-Mammalian-Based Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    10. Biopharmaceutical Contract Manufacturing Market – Geographic Analysis

    10.1 North America: Biopharmaceutical Contract Manufacturing Market

    10.1.1 Overview

    10.1.2 North America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.1.3 North America: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.1.3.1 North America: Biologics Market, 2019-2028 (USD Million)

    10.1.4 North America: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.1.4.1 North America: Process Development Market, 2019-2028 (USD Million)

    10.1.5 North America: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.1.6 North America: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

    10.1.6.1 US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.1.6.1.1 US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.1.6.1.2 US: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.1.6.1.2.1 US: Biologics Market, 2019-2028 (USD Million)

    10.1.6.1.3 US: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.1.6.1.3.1 US: Process Development Market, 2019-2028 (USD Million)

    10.1.6.1.4 US: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.1.6.2 Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.1.6.2.1 Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.1.6.2.2 Canada: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.1.6.2.2.1 Canada: Biologics Market, 2019-2028 (USD Million)

    10.1.6.2.3 Canada: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.1.6.2.3.1 Canada: Process Development Market, 2019-2028 (USD Million)

    10.1.6.2.4 Canada: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.1.6.3 Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.1.6.3.1 Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.1.6.3.2 Mexico: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.1.6.3.2.1 Mexico: Biologics Market, 2019-2028 (USD Million)

    10.1.6.3.3 Mexico: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.1.6.3.3.1 Mexico: Process Development Market, 2019-2028 (USD Million)

    10.1.6.3.4 Mexico: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.2 Europe: Biopharmaceutical Contract Manufacturing Market

    10.2.1 Overview

    10.2.2 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2028 (USD Million)

    10.2.3 Europe: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.2.3.1 Europe: Biologics Market, 2019-2028 (USD Million)

    10.2.4 Europe: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.2.4.1 Europe: Process Development Market, 2019-2028 (USD Million)

    10.2.5 Europe: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.2.6 Europe: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

    10.2.6.1 Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.2.6.1.1 Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.2.6.1.2 Germany: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.2.6.1.2.1 Germany: Biologics Market, 2019-2028 (USD Million)

    10.2.6.1.3 Germany: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.2.6.1.3.1 Germany: Process Development Market, 2019-2028 (USD Million)

    10.2.6.1.4 Germany: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.2.6.2 UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.2.6.2.1 UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.2.6.2.2 UK: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.2.6.2.2.1 UK: Biologics Market, 2019-2028 (USD Million)

    10.2.6.2.3 UK: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.2.6.2.3.1 UK: Process Development Market, 2019-2028 (USD Million)

    10.2.6.2.4 UK: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.2.6.3 France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.2.6.3.1 France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.2.6.3.2 France: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.2.6.3.2.1 France: Biologics Market, 2019-2028 (USD Million)

    10.2.6.3.3 France: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.2.6.3.3.1 France: Process Development Market, 2019-2028 (USD Million)

    10.2.6.3.4 France: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.2.6.4 Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.2.6.4.1 Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.2.6.4.2 Spain: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.2.6.4.2.1 Spain: Biologics Market, 2019-2028 (USD Million)

    10.2.6.4.3 Spain: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.2.6.4.3.1 Spain: Process Development Market, 2019-2028 (USD Million)

    10.2.6.4.4 Spain: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.2.6.5 Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.2.6.5.1 Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.2.6.5.2 Italy: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.2.6.5.2.1 Italy: Biologics Market, 2019-2028 (USD Million)

    10.2.6.5.3 Italy: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.2.6.5.3.1 Italy: Process Development Market, 2019-2028 (USD Million)

    10.2.6.5.4 Italy: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.2.6.6 Rest of Europe: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.2.6.6.1 Rest of Europe: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.2.6.6.2 Rest of Europe: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.2.6.6.2.1 Rest of Europe: Biologics Market, 2019-2028 (USD Million)

    10.2.6.6.3 Rest of Europe: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.2.6.6.3.1 Rest of Europe: Process Development Market, 2019-2028 (USD Million)

    10.2.6.6.4 Rest of Europe: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market

    10.3.1 Overview

    10.3.2 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2028 (USD Million)

    10.3.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.3.3.1 Asia Pacific: Biologics Market, 2019-2028 (USD Million)

    10.3.4 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.3.4.1 Asia Pacific: Process Development Market, 2019-2028 (USD Million)

    10.3.5 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.3.6 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

    10.3.6.1 China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.3.6.1.1 China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.3.6.1.2 China: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.3.6.1.2.1 China: Biologics Market, 2019-2028 (USD Million)

    10.3.6.1.3 China: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.3.6.1.3.1 China: Process Development Market, 2019-2028 (USD Million)

    10.3.6.1.4 China: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.3.6.2 Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.3.6.2.1 Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.3.6.2.2 Japan: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.3.6.2.2.1 Japan: Biologics Market, 2019-2028 (USD Million)

    10.3.6.2.3 Japan: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.3.6.2.3.1 Japan: Process Development Market, 2019-2028 (USD Million)

    10.3.6.2.4 Japan: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.3.6.3 India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.3.6.3.1 India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.3.6.3.2 India: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.3.6.3.2.1 India: Biologics Market, 2019-2028 (USD Million)

    10.3.6.3.3 India: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.3.6.3.3.1 India: Process Development Market, 2019-2028 (USD Million)

    10.3.6.3.4 India: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.3.6.4 South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.3.6.4.1 South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.3.6.4.2 South Korea: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.3.6.4.2.1 South Korea: Biologics Market, 2019-2028 (USD Million)

    10.3.6.4.3 South Korea: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.3.6.4.3.1 South Korea: Process Development Market, 2019-2028 (USD Million)

    10.3.6.4.4 South Korea: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.3.6.5 Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.3.6.5.1 Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.3.6.5.2 Australia: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.3.6.5.2.1 Australia: Biologics Market, 2019-2028 (USD Million)

    10.3.6.5.3 Australia: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.3.6.5.3.1 Australia: Process Development Market, 2019-2028 (USD Million)

    10.3.6.5.4 Australia: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.3.6.6 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.3.6.6.1 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.3.6.6.2 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.3.6.6.2.1 Rest of Asia Pacific: Biologics Market, 2019-2028 (USD Million)

    10.3.6.6.3 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.3.6.6.3.1 Rest of Asia Pacific: Process Development Market, 2019-2028 (USD Million)

    10.3.6.6.4 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market

    10.4.1 Overview

    10.4.2 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2028 (USD Million)

    10.4.3 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.4.3.1 Middle East & Africa: Biologics Market, 2019-2028 (USD Million)

    10.4.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.4.4.1 Middle East & Africa: Process Development Market, 2019-2028 (USD Million)

    10.4.5 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.4.6 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Share by Country – 2021 & 2028, (%)

    10.4.6.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.4.6.1.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.4.6.1.2 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.4.6.1.2.1 Saudi Arabia: Biologics Market, 2019-2028 (USD Million)

    10.4.6.1.3 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.4.6.1.3.1 Saudi Arabia: Process Development Market, 2019-2028 (USD Million)

    10.4.6.1.4 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.4.6.2 UAE: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.4.6.2.1 UAE: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.4.6.2.2 UAE: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.4.6.2.2.1 UAE: Biologics Market, 2019-2028 (USD Million)

    10.4.6.2.3 UAE: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.4.6.2.3.1 UAE: Process Development Market, 2019-2028 (USD Million)

    10.4.6.2.4 UAE: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.4.6.3 South Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    10.4.6.3.1 South Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.4.6.3.2 South Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.4.6.3.2.1 South Africa: Biologics Market, 2019-2028 (USD Million)

    10.4.6.3.3 South Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.4.6.3.3.1 South Africa: Process Development Market, 2019-2028 (USD Million)

    10.4.6.3.4 South Africa: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.4.6.4 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    10.4.6.4.1 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.4.6.4.2 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.4.6.4.2.1 Rest of Middle East and Africa: Biologics Market, 2019-2028 (USD Million)

    10.4.6.4.3 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.4.6.4.3.1 Rest of Middle East and Africa: Process Development Market, 2019-2028 (USD Million)

    10.4.6.4.4 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.5 South and Central America: Biopharmaceutical Contract Manufacturing Market

    10.5.1 Overview

    10.5.2 South and Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2028 (US$ Million)

    10.5.3 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.5.3.1 South and Central America: Biologics Market, 2019-2028 (USD Million)

    10.5.4 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.5.4.1 South and Central America: Process Development Market, 2019-2028 (USD Million)

    10.5.5 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.5.6 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

    10.5.6.1 Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.5.6.1.1 Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.5.6.1.2 Brazil: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.5.6.1.2.1 Brazil: Biologics Market, 2019-2028 (USD Million)

    10.5.6.1.3 Brazil: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.5.6.1.3.1 Brazil: Process Development Market, 2019-2028 (USD Million)

    10.5.6.1.4 Brazil: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.5.6.2 Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.5.6.2.1 Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.5.6.2.2 Argentina: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.5.6.2.2.1 Argentina: Biologics Market, 2019-2028 (USD Million)

    10.5.6.2.3 Argentina: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.5.6.2.3.1 Argentina: Process Development Market, 2019-2028 (USD Million)

    10.5.6.2.4 Argentina: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    10.5.6.3 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.5.6.3.1 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    10.5.6.3.2 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

    10.5.6.3.2.1 Rest of South and Central America: Biologics Market, 2019-2028 (USD Million)

    10.5.6.3.3 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

    10.5.6.3.3.1 Rest of South and Central America: Process Development Market, 2019-2028 (USD Million)

    10.5.6.3.4 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

    11. Impact of COVID-19 Pandemic on Biopharmaceutical Contract Manufacturing Market

    11.1 North America: Impact Assessment of COVID-19 Pandemic

    11.2 Europe: Impact Assessment of COVID-19 Pandemic

    11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

    11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

    11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

    12. Biopharmaceutical Contract Manufacturing Market – Industry Landscape

    12.1 Overview

    12.2 Growth Strategies Done by the Companies in the Market, (%)

    12.3 Organic Developments

    12.3.1 Overview

    12.4 Inorganic Developments

    12.4.1 Overview

    13. Company Profiles

    13.1 Boehringer Ingelheim International GmbH

    13.1.1 Key Facts

    13.1.2 Business Description

    13.1.3 Products and Services

    13.1.4 Financial Overview

    13.1.5 SWOT Analysis

    13.1.6 Key Developments

    13.2 THERMO FISHER SCIENTIFIC INC.

    13.2.1 Key Facts

    13.2.2 Business Description

    13.2.3 Products and Services

    13.2.4 Financial Overview

    13.2.5 SWOT Analysis

    13.2.6 Key Developments

    13.3 General Electric Company

    13.3.1 Key Facts

    13.3.2 Business Description

    13.3.3 Products and Services

    13.3.4 Financial Overview

    13.3.5 SWOT Analysis

    13.3.6 Key Developments

    13.4 MERCK KGAA

    13.4.1 Key Facts

    13.4.2 Business Description

    13.4.3 Products and Services

    13.4.4 Financial Overview

    13.4.5 SWOT Analysis

    13.4.6 Key Developments

    13.5 Lonza

    13.5.1 Key Facts

    13.5.2 Business Description

    13.5.3 Products and Services

    13.5.4 Financial Overview

    13.5.5 SWOT Analysis

    13.5.6 Key Developments

    13.6 Samsung Biologics

    13.6.1 Key Facts

    13.6.2 Business Description

    13.6.3 Products and Services

    13.6.4 Financial Overview

    13.6.5 SWOT Analysis

    13.6.6 Key Developments

    13.7 AbbVie Inc.

    13.7.1 Key Facts

    13.7.2 Business Description

    13.7.3 Products and Services

    13.7.4 Financial Overview

    13.7.5 SWOT Analysis

    13.7.6 Key Developments

    13.8 WUXI BIOLOGICS

    13.8.1 Key Facts

    13.8.2 Business Description

    13.8.3 Products and Services

    13.8.4 Financial Overview

    13.8.5 SWOT Analysis

    13.8.6 Key Developments

    13.9 Ajinomoto Co. Inc.

    13.9.1 Key Facts

    13.9.2 Business Description

    13.9.3 Products and Services

    13.9.4 Financial Overview

    13.9.5 SWOT Analysis

    13.9.6 Key Developments

    13.10 Inno Bio Ventures Sdn Bhd

    13.10.1 Key Facts

    13.10.2 Business Description

    13.10.3 Products and Services

    13.10.4 Financial Overview

    13.10.5 SWOT Analysis

    13.10.6 Key Developments

    14. Appendix

    14.1 About The Insight Partners

    14.2 Glossary of Terms

    LIST OF TABLES

    Table 1. North America Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 2. North America Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 3. North America Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 4. North America Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 5. North America Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 6. US Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 7. US Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 8. US Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 9. US Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 10. US Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 11. Canada Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 12. Canada Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 13. Canada Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 14. Canada Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 15. Canada Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 16. Mexico Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 17. Mexico Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 18. Mexico Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 19. Mexico Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 20. Mexico Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 21. Europe Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 22. Europe Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 23. Europe Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 24. Europe Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 25. Europe Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 26. Germany Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 27. Germany Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 28. Germany Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 29. Germany Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 30. Germany Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 31. UK Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 32. UK Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 33. UK Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 34. UK Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 35. UK Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 36. France Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 37. France Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 38. France Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 39. France Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 40. France Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 41. Spain Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 42. Spain Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 43. Spain Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 44. Spain Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 45. Spain Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 46. Italy Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 47. Italy Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 48. Italy Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 49. Italy Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 50. Italy Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 51. Rest of Europe Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 52. Rest of Europe Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 53. Rest of Europe Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 54. Rest of Europe Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 55. Rest of Europe Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 56. Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 57. Asia Pacific Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 58. Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 59. Asia Pacific Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 60. Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 61. China Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 62. China Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 63. China Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 64. China Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 65. China Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 66. Japan Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 67. Japan Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 68. Japan Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 69. Japan Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 70. Japan Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 71. India: R&D spending of Pharmaceutical companies (2010 & 2017)

    Table 72. India Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 73. India Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 74. India Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 75. India Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 76. India Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 77. South Korea Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 78. South Korea Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 79. South Korea Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 80. South Korea Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 81. South Korea Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 82. Australia Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 83. Australia Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 84. Australia Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 85. Australia Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 86. Australia Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 87. Rest of Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 88. Rest of Asia Pacific Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 89. Rest of Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 90. Rest of Asia Pacific Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 91. Rest of Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 92. Middle East & Africa Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 93. Middle East & Africa Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 94. Middle East & Africa Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 95. Middle East & Africa Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 96. Middle East & Africa Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 97. Saudi Arabia Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 98. Saudi Arabia Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 99. Saudi Arabia Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 100. Saudi Arabia Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 101. Saudi Arabia Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 102. UAE Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 103. UAE Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 104. UAE Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 105. UAE Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 106. UAE Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 107. South Africa Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 108. South Africa Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 109. South Africa Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 110. South Africa Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 111. South Africa Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 112. Rest of Middle East and Africa Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 113. Rest of Middle East and Africa Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 114. Rest of Middle East and Africa Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 115. Rest of Middle East and Africa Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 116. Rest of Middle East and Africa Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 117. South and Central America Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 118. South and Central America Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 119. South and Central America Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 120. South and Central America Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 121. South and Central America Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 122. Brazil Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 123. Brazil Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 124. Brazil Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 125. Brazil Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 126. Brazil Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 127. Argentina Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 128. Argentina Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 129. Argentina Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 130. Argentina Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 131. Argentina Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 132. Rest of South and Central America Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

    Table 133. Rest of South and Central America Biologics Market – Revenue and Forecast to 2028 (USD Million)

    Table 134. Rest of South and Central America Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

    Table 135. Rest of South and Central America Process Development Market – Revenue and Forecast to 2028 (USD Million)

    Table 136. Rest of South and Central America Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

    Table 137. Organic Developments Done By Companies

    Table 138. Inorganic Developments Done By Companies

    Table 139. Glossary of Terms, Biopharmaceutical Contract Manufacturing Market

    LIST OF FIGURES

    Figure 1. Biopharmaceutical Contract Manufacturing Market Segmentation

    Figure 2. Biopharmaceutical Contract Manufacturing Segmentation, By Region

    Figure 3. Global Biopharmaceutical Contract Manufacturing Market Overview

    Figure 4. Biologics Segment Held Largest Share Of Product In Biopharmaceutical Contract Manufacturing Market

    Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

    Figure 6. Global Biopharmaceutical Contract Manufacturing Market, By Geography (US$ Million)

    Figure 7. Global Biopharmaceutical Contract Manufacturing Market- Leading Country Markets (US$ Million)

    Figure 8. Global Biopharmaceutical Contract Manufacturing Market, Industry Landscape

    Figure 9. North America PEST Analysis

    Figure 10. Europe PEST Analysis

    Figure 11. Asia Pacific PEST Analysis

    Figure 12. Middle East and Africa (MEA) PEST Analysis

    Figure 13. South and Central America PEST Analysis

    Figure 14. Biopharmaceutical Contract Manufacturing Market Impact Analysis of Drivers and Restraints

    Figure 15. Global Biopharmaceutical Contract Manufacturing Market – Revenue Forecast and Analysis – 2020 - 2028

    Figure 16. Global Biopharmaceutical Contract Manufacturing Market – By Geography Forecast And Analysis – 2019- 2028

    Figure 17. Market Positioning Of Key Players In Global Biopharmaceutical Contract Manufacturing Market

    Figure 18. Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2021 and 2028)

    Figure 19. Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 20. Monoclonal Antibodies: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 21. Recombinant Proteins: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 22. Vaccines: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 23. Others: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 24. Biosimilar: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 25. Biopharmaceuticals Contract Manufacturing Market, by Service, 2021 and 2028 (%)

    Figure 26. Process Development: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 27. Downstream Processing: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 28. Upstream Processing: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 29. Fill and Finish Operations: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 30. Analytical and Quality Control Studies: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 31. Packaging: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 32. Biopharmaceuticals Contract Manufacturing Market, by Source, 2021 and 2028 (%)

    Figure 33. Mammalian-Based Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 34. Microbial/Non-Mammalian-Based Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 35. North America: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2021) (USD Million)

    Figure 36. North America Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2028 (USD Million)

    Figure 37. North America: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

    Figure 38. US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 39. Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 40. Projection of the Use of Pharmaceutical Products in Mexico (Million Dollars)

    Figure 41. Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 42. Europe: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2021) (USD Million)

    Figure 43. Europe Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2028 (USD Million)

    Figure 44. Europe: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

    Figure 45. Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 46. UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 47. France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 48. Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 49. Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 50. Rest of Europe: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 51. Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2021) (USD Million)

    Figure 52. Asia Pacific Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2028 (USD Million)

    Figure 53. Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

    Figure 54. China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 55. Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 56. India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 57. South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 58. Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 59. Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 60. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2021) (USD Million)

    Figure 61. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2028 (USD Million)

    Figure 62. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Share by Country – 2021 & 2028, (%)

    Figure 63. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 64. UAE: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 65. South Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 66. Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 67. South and Central America: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2021) (USD Million)

    Figure 68. South and Central America Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2028 (USD Million)

    Figure 69. South and Central America: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

    Figure 70. Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 71. Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 72. Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

    Figure 73. IMPACT OF COVID-19 PANDEMIC IN NORTH AMERICAN COUNTRY MARKETS

    Figure 74. IMPACT OF COVID-19 PANDEMIC IN EUROPEAN COUNTRY MARKETS

    Figure 75. IMPACT OF COVID-19 PANDEMIC IN ASIA-PACIFIC COUNTRY MARKETS

    Figure 76. IMPACT OF COVID-19 PANDEMIC IN MIDDLE EAST AND AFRICAN COUNTRY MARKETS

    Figure 77. IMPACT OF COVID-19 PANDEMIC IN SOUTH AND CENTRAL AMERICAN COUNTRY MARKETS

    Figure 78. Growth Strategies Done by the Companies in the Market, (%)

    The List of Companies - Biopharmaceuticals Contract Manufacturing Market

    1. Lonza AG
    2. Boehringer Ingelheim Biopharmaceuticals GmbH
    3.  Inno Bio Ventures Sdn Bhd
    4. Thermo Fisher Scientific, Inc.  
    5. AbbVie, Inc.
    6. WuXi Biologics, Inc.
    7. General Electric Co.
    8. Samsung Biologics Co. Ltd.
    9. Merck KGaA
    10. Ajinomoto Co. Inc.
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the biopharmaceuticals contract manufacturing market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global biopharmaceuticals contract manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
    TIPRE00005512
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount